Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Assess the pros and cons of emergency versus sinking funds to determine which is more suitable for your goals, and how to combine them effectively.
23,964 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
As AI investment surges, the real cash flow winners are the hardware and infrastructure suppliers. Analysts say forge...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
Polunsky Beitel Green expands its Dallas-based business development team with Jeanine LaMay Kay, signaling a broader ...
OpenAI’s CFO unveils a four-question framework to assess whether AI spending actually delivers value. The approach fo...
AD Mortgage has sent a policy letter to the FHFA raising concerns about proposed condo financing criteria changes for...
Five dividend-paying giants have sat on Goldman Sachs' Conviction List the longest, underscoring steady income as mar...
Royal Caribbean deploys AI to forecast demand, trim waste, and tailor guest experiences, signaling a data-driven shif...
Philip Morris International is steering a bold pivot toward smoke-free products, aiming to drive more than two-thirds...
A retail-tech veteran leads Elevance Health’s push to modernize consumer experience and cost clarity in health benefi...
Real-world assets are flowing into on-chain markets as AI-enabled DeFi trading grows. Galaxy Digital and Ondo report ...
Geopolitical headlines sparked a wild crypto swing. Bitcoin briefly climbed toward the $70K mark as traders weighed r...